Search all trials

Find therapies in clinical trials near you – page 194

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Endometrial cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Ovarian cancer recurrent

Not recruiting

Registered drug

Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Hepatic encephalopathy

Not recruiting

Investigational

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Rifaximin

Contact Research Centre

Orthostatic hypotension

Not recruiting

Registered drug

Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Ampreloxetine

Contact Research Centre

Marginal zone lymphoma+1

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Sar442970

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Nivolumab

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Find therapies in clinical trials near you – page 194

2 388 trials match your criteria

Endometrial cancer

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Ovarian cancer recurrent

Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Renal cell carcinoma

Study of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer

Neoplasm

Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

Hepatic encephalopathy

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Orthostatic hypotension

Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Marginal zone lymphoma+1

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Dementia Alzheimer's type

Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia

Hidradenitis

Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

Hodgkin's disease

Study of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma

Triple negative breast cancer

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Dermatitis atopic

Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.